In asymptomatic adults with T2D requiring IBT, a fixed-ratio co-formulation insulin/GLP-1 RA SHOULD BE CONSIDERED over basal insulin or basal-bolus insulin, whenever available, to improve glucose control. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.